logo
nav-bg
Home>Events

English

Events

October 20, 2019 Summit Forum on Specific Programs for China’s Cerebrovascular Disease Prevention, Treatment and Technological Development

On October 20th 2019, Summit Forum on Specific Programs for China’s Cerebrovascular Disease Prevention, Treatment and Technological Development successfully concluded in Beijing. The conference was jointly organized by the National Clinical Research Center for Neurological Diseases (NCRCND), Beijing Tiantan Hospital Capital Medical University, Chinese Center for Disease Control and Prevention(CCDC) and the Chinese Stroke Association(CSA).
 
More than 40 experts from health administration, China Center for Disease Control and Prevention and universities attended the meeting, including world-renowned scholars Valery Feigin (director and professor of the national institute for stroke and applied neurosciences at University of Auckland), Zhengming Chen (professor of epidemiology at University of Oxford). All the experts contributed actively to panel discussions in the field of preventative policy and strategy, clinical research and epidemiology, healthcare quality surveillance, and implementation plans for disease management and rehabilitation.
 
The summit offered a valuable high-level platform, sharing most recent academic findings, introducing cutting-edge technologies to aid disease prevention and treatment, exchanging first-hand experience and recommendations for best practices. Officials from the Disease Prevention and Control Bureau of the National Health Commission highly praised National Clinical Research Center’s initiatives to enact the Healthy China Action 2030, and its effort to consolidate a long-term strategic plan for cerebrovascular disease prevention, treatment and rehabilitation.
 
The summit forum was closed with an in-depth discussion on policies and research directions, prevention and management approaches, and implementation and surveillance strategies, which have produced significant and fruitful outcomes. The conference was a great opportunity to exchange experience, discuss directions, identify and affirm priorities to put at the forefront of the long-term strategic plan for cerebrovascular disease prevention, treatment and management in China.
 
Experts attending the meeting agreed that China's cerebrovascular disease burden is heavy, prevention and treatment is urgent. Cerebrovascular diseases can be prevented and controlled. The successful prevention and treatment experience of European and American countries can be referred to. The following consensus was reached at the meeting, including the establishment of a working group on stroke risk prediction tools in China, the establishment of a national big data sharing platform for cerebrovascular diseases, the organization of experts to compile a Health China plan on Cerebrovascular Disease Prevention and Control and Strategic Plan for Scientific Research on Cerebrovascular Diseases in China.